Advanced therapies that tackle diseases or conditions using modified cells or genetics are becoming more common in the field of medicine, as they hold the promise of curing previously untreatable diseases like cancers or genetic conditions like Duchenne muscular dystrophy. However, many of these therapies are highly personalized, to the point where receiving another patient’s therapy could prove fatal. This and the fragile nature of the biological components makes producing, shipping, handling, and storage of these therapies extremely challenging.
TrakCel Limited strives to help therapy developers resolve these challenges in an efficient way, by creating software solutions (Cell Orchestration Systems) that ensure the right patient receives the right therapy, at the right time.
TrakCel’s primary cell orchestration platform is OCELLOS which connects users and information from the entire supply chain in an intuitive series of dashboards, reports and tasks that progress and track each patient’s individual therapy. This means that healthcare providers can effectively schedule appointments and treatments and delays or issues in manufacturing or shipping can be responded to in the very narrow window of time before a therapy becomes unusable.
OCELLOS cell orchestration also keeps a full record of who has had possession of a therapy or sample, the conditions it was stored in and exactly which patient it belongs to and keeps a full electronic audit trail, removing the need for outdated paper records, increasing efficiency and driving down costs whilst keeping patients safe. Visit the website or get in touch with the TrakCel team today to find out more!
Innovative OCELLOS tech
TrakCel’s OCELLOS product is an intuitive and innovative, modular cellular orchestration solution backed by world-class professional services. Its modular nature means it is easily deployed and configured precisely to each therapy it tracks.
OCELLOS is rapidly revolutionizing the CGT industry, paving the way for effortless communication and empowering healthcare providers to work more efficiently than ever before. By using this technology, healthcare professionals can seamlessly enroll new patients, schedule the collection of starting materials, and see each patient’s therapy status in real-time – all without any hassle or unnecessary paperwork. What is more, this can be shared with supply chain partners such as specialist shipping, manufacturing, and lab services so they see only the information that they need to undertake their tasks.
OCELLOS calculates the ideal timeline for each therapy and can automatically schedule shipping and manufacturing slots in line with availability. This impressive integration and detailed levels of insight and visibility that OCELLOS offers can also help to prevent serious or costly mistakes by enabling therapy experts access to alerts and notifications of any issues in real time so they can be dealt with promptly.
Why choose TrakCel?
TrakCel has a wealth of experience in the industry, working with many live deployments supporting many therapy types so you know that by choosing to work with the team there you’ll benefit from a wealth of knowledge and experience of proven industry processes. Alongside this unrivalled understanding, you’ll benefit from TrakCel’s existing integrated partner eco-system including couriers, manufacturing, HLA matching, patient hub services, and many more.
Since being founded in 2012, TrakCel has worked tirelessly to revolutionize how cell and gene therapies are delivered to patients with innovative, scalable, and insightful solutions. The company has gone from strength to strength, driving innovation and developments in cellular orchestration by migrating to a SAAS model on the Salesforce.com platform with MuleSoft API connectivity, thus creating a system build for efficient and secure connectivity throughout the supply chain. TrakCel has been featured in BioWorld, Bloomberg, Fierce Biotech and the Medicine Maker, and is trusted by advanced therapy developers all over the world.
About TrakCel
TrakCel is a market leading developer of integrated technologies specifically created in 2012 to manage the international autologous and allogeneic cell, gene and immunotherapy supply chain. TrakCel’s software platform has been developed in collaboration with, and increasingly adopted by leading companies in the cell, gene and immunotherapy industries. TrakCel’s solutions deliver real-time control over the entire therapeutic supply chain, from sample collection through manufacturing to treatment delivery. The TrakCel platform accelerates global scale-up and scale-out of cell and gene therapy products, increasing efficiency and decreasing complexity, while maintaining treatment collection to administration compliance and traceability. TrakCel’s Cardiff office remains their European headquarters with US offices in California and New Jersey.